Parkinson's disease is a progressive neurological disorder caused by the death or damage of certain brain cells, called neurons. It affects the ability to move, control facial expression, and other motor functions. Symptoms of the disease include tremors, muscle rigidity, slow movement, balance problems, and difficulty speaking and swallowing. Other common side effects include depression, cognitive problems, sleep disturbances, and urinary incontinence. Parkinson's disease is caused when certain neurons (nerve cells) in the part of the brain responsible for movement (called the substantia nigra) die or become damaged. These cells are responsible for producing the neurotransmitter dopamine, which helps the brain control movement and coordination. When these cells die or become damaged, it causes a lack of dopamine in the brain, resulting in impaired movement. There is no known cure for Parkinson's disease. However, there are several treatments available that can help to improve the symptoms. Treatment options include medications to increase dopamine levels in the brain, physical therapy to improve mobility and coordination, and surgery to implant deep brain stimulators (DBS) to help manage motor deficits and manage tremors. While there is no known exact cause of Parkinson's disease, there are a few risk factors that can increase a person's chances of developing the disease. Age is believed to play a role, with most people being diagnosed at 50 years or older. Other risk factors include genetics, exposure to environmental toxins, and previous head injuries. While there is no cure for Parkinson's disease, research is being done to find treatments and ways to slow the progression of the disease. Researchers have found that lifestyle and diet modifications can help, as well as finding ways to reduce stress. In addition, new medications and treatments are being developed that could potentially slow the disease and enable people to lead longer, more productive lives.
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : In silico in vitro and in vivo study of geraniol role in Alzheimer's disease
Bhuvanesh Baniya, Mohanlal Sukhadia University, India
Title : Prince transform: a wave-mechanical framework for real-time EEG analysis and early seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Gut-brain axis in autism spectrum disorder: MicroRNAs as a critical mediator of pathogenesis
Rahem Rahmati, Shahrekord University of Medical Sciences, Iran (Islamic Republic of)